The development was started for veterinary, but results show us an ability to use this product for human too. At first stage we will receive license for veterinary and will start to promote the products. On next stage we plan to conduct clinical studies for human, make license and expand the scope of the drug. You may see our plans in roadmap.

Hi, the Alpha-1 release is planned for July.

Yes sure. The fees are so small that businesses would have less of the benefits when conducting business off of the platform. As you've said yourself, yes. It makes it much easier for them to search and vet new business partners.